Table 1.
Baseline characteristics of the Sinikithemba paediatric cohort
| Demography | [n (%)] |
| Children | 151 |
| Female | 77 (51.0%) |
| Age | |
| < 3 years | 39 (25.8%) |
| 3–5 years | 43 (28.5%) |
| 6–8 years | 43 (28.5%) |
| ≥ 9 years | 26 (17.2%) |
| Median years [range] | 5.7 [.3–15.4] |
| Parent status | [n (%)] |
| Two parents alive | 67 (44.4%) |
| Only father living | 19 (12.6%) |
| Only mother living | 27 (17.9%) |
| Neither parent living | 38 (25.1%) |
| WHO clinical stage [n (%)] | [n (%)] |
| Stage 1 | 26 (17.2%) |
| Stage 2 | 19 (12.6%) |
| Stage 3 | 72 (47.7%) |
| Stage 4 | 34 (22.5%) |
| Anthropometry | Median (IQR) |
| Weight-for-age Z-score | -1.9 (-3.6 to -0.9) |
| Height-for-age Z-score | -2.2 (-3.0 to -1.1) |
| CD4 lymphocyte % | [n (%)] |
| < 5% | 52 (35.6%) |
| 5%-9% | 36 (24.7%) |
| 10%-14% | 28 (19.2%) |
| 15%-24% | 26 (17.8%) |
| > 25% | 4 (2.7%) |
| Median CD4% (IQR) | 7.4 (2.1–13.7) |
| Laboratory values | Median (IQR) |
| Albumin (g/L) | 30.0 (26.0–35.0) |
| ALT (IU/L) | 18.0 (14.0–28.3) |
| Hemoglobin (g/dl) | 10.1 (8.9–11.0) |
| Tuberculosis | [n (%)] |
| Present | 50 (33.1%) |
| Other opportunistic infections | [n (%)] |
| Chronic gastroenteritis | 52 (34.4%) |
| Pneumonia | 13 (8.6%) |
| Oesophageal candidiasis | 13 (8.6%) |
| PCP | 11 (7.3%) |
| Cryptococcal meningitis | 1 (0.7%) |
| CMV retinitis | 0 |
| Toxoplosmosis | 0 |